Literature DB >> 18463097

Hu antigen R (HuR) functions as an alternative pre-mRNA splicing regulator of Fas apoptosis-promoting receptor on exon definition.

José M Izquierdo1.   

Abstract

Exclusion of exon 6 by alternative RNA splicing of the primary transcript of the apoptosis receptor Fas produces a soluble isoform that prevents programmed cell death. I report that antiapoptotic regulator Hu antigen R (HuR, ELAVL1), a member of the embryonic lethal, abnormal vision, Drosophila-like (ELAVL) family, promotes Fas exon 6 skipping by binding to an exonic splicing silencer. HuR inhibits the association of U2 small nuclear ribonucleoprotein (snRNP) auxiliary factor 65 kDa (U2AF65) with the upstream 3' splice site, without decreasing recognition of the downstream 5' splice site by U1 snRNP but by antagonizing the role of TIA-1 (T-cell intracellular antigen 1)/TIAR (TIA-1 related protein) on exon definition. Remarkably, U1 snRNP-mediated recognition of the 5' splice site is partially required for efficient U2AF65 inhibition. Further, the silencing capacity of HuR as splicing regulator resides in the RRM1 and hinge-RRM3 domains. Taken together, these results support a functional link between HuR as repressor of alternative Fas splicing and the molecular mechanisms modulating programmed cell death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463097     DOI: 10.1074/jbc.M800017200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

Review 1.  Posttranscriptional regulation of cancer traits by HuR.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-06       Impact factor: 9.957

2.  HuR antagonizes the effect of an intronic pyrimidine-rich sequence in regulating WT1 +/-KTS isoforms.

Authors:  Hui Li; Shuai Hou; Tian Hao; Sikandar Azam; Caigang Liu; Lei Shi; Haixin Lei
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 3.  Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged.

Authors:  Charles J David; James L Manley
Journal:  Genes Dev       Date:  2010-11-01       Impact factor: 11.361

4.  The emerging role of splicing factors in cancer.

Authors:  Ana Rita Grosso; Sandra Martins; Maria Carmo-Fonseca
Journal:  EMBO Rep       Date:  2008-10-10       Impact factor: 8.807

Review 5.  T-cell intracellular antigens in health and disease.

Authors:  Carmen Sánchez-Jiménez; José M Izquierdo
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  Hu proteins regulate alternative splicing by inducing localized histone hyperacetylation in an RNA-dependent manner.

Authors:  Hua-Lin Zhou; Melissa N Hinman; Victoria A Barron; Cuiyu Geng; Guangjin Zhou; Guangbin Luo; Ruth E Siegel; Hua Lou
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-01       Impact factor: 11.205

7.  Activation of HuR downstream of p38 MAPK promotes cardiomyocyte hypertrophy.

Authors:  Samuel Slone; Sarah R Anthony; Xiaoqing Wu; Joshua B Benoit; Jeffrey Aube; Liang Xu; Michael Tranter
Journal:  Cell Signal       Date:  2016-08-10       Impact factor: 4.315

8.  CUGBP2 directly interacts with U2 17S snRNP components and promotes U2 snRNA binding to cardiac troponin T pre-mRNA.

Authors:  Young-Hwa Goo; Thomas A Cooper
Journal:  Nucleic Acids Res       Date:  2009-05-14       Impact factor: 16.971

9.  Promotion of exon 6 inclusion in HuD pre-mRNA by Hu protein family members.

Authors:  Huiwen Wang; Jill Molfenter; Hui Zhu; Hua Lou
Journal:  Nucleic Acids Res       Date:  2010-02-16       Impact factor: 16.971

10.  Depletion of T-cell intracellular antigen proteins promotes cell proliferation.

Authors:  Raquel Reyes; José Alcalde; José M Izquierdo
Journal:  Genome Biol       Date:  2009-08-26       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.